Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertugliflozin Dose-Ranging Study in T2DM
NCT01059825Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Feb 2010
- Primary completion
- Jan 2011
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ertugliflozin in type 2 diabetes mellitus (T2DM), sponsored by Merck & Co.. Started Feb 2010; status: completed.
02
Drugs
ertugliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01059825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01059825.